Literature DB >> 1689895

Infections with FK 506 immunosuppression: preliminary results with primary therapy.

M Alessiani1, S Kusne, F M Martin, J J Fung, A Jain, S Todo, R Simmons, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689895      PMCID： PMC2903870     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation.

Authors:  N Singh; J S Dummer; S Kusne; L Makowka; T E Starzl; M Ho
Journal:  Transplant Proc       Date:  1988-02-01       Impact factor: 1.066

2.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction.

Authors:  B C Wu; J N Dowling; J A Armstrong; M Ho
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

4.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

5.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

Authors:  N Singh; J S Dummer; S Kusne; M K Breinig; J A Armstrong; L Makowka; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226
  5 in total
  6 in total

1.  Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.

Authors:  S Kusne; J Fung; M Alessiani; M Martin; J Torre-Cisneros; W Irish; L Ondick; A Jain; K Abu-Elmagd; S Takaya
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

2.  Infections in adult liver transplant patients under FK 506 immunosuppression.

Authors:  M Alessiani; S Kusne; M Martin; A Jain; K Abu-Elmagd; J Moser; S Todo; J Fung; T Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 3.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.

Authors:  M Sakr; T Hassanein; J Gavaler; K Abu-Elmagd; J Fung; R Gordon; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

5.  Recent advances in hepatic transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; O Bronsther; A Jain; W Irish; H Ramos; I R Marino; F Dodson; R Selby; H Doyle; H Furukawa
Journal:  Clin Transpl       Date:  1993

6.  Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants.

Authors:  Yujiro Henmi; Kazuki Kakimoto; Takuya Inoue; Kei Nakazawa; Minori Kubota; Azusa Hara; Takashi Mikami; Yutaka Naka; Yuki Hirata; Yoshimasa Hirata; Taisuke Sakanaka; Sadaharu Nouda; Toshihiko Okada; Ken Kawakami; Toshihisa Takeuchi; Kazunari Tominaga; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2018-06-08       Impact factor: 3.114
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.